Congratulations
to Alexandra Tate on the award for best student paper for her “Treatment
Recommendations in Oncology Visits: Implications for Patient Agency and
Physician Authority,” published in Health
Communication, 2018.
This
study provides an exemplar of medical CA at its best; it provides new insights
into how doctor-patient interaction varies across stages of the oncology
encounter. The crucial question asked by Tate is how physician-oncologist and
patient negotiate decision making for treatment and, in particular, how physicians
assert their authority — and balance it
with an orientation to the patient’s agency — in oncology regarding
treatment. Making use of Stivers’ typologies for primary care treatment
recommendations, Tate found that while oncologists’ proposals were most
common in the initial stage of oncologist/patient interaction, when the
oncologist needed the patient to buy into a certain treatment, during other
stages (mid-course treatment and ancillary treatments) pronouncements were
made. Differentiated forms of verbal action are accounted for with respect to
the trajectory of the voyage of cancer treatment. A deviant case provides
insight into the importance of the relationship of doctor and patient regarding
how negotiation proceeds; when a relationship is new midcourse of treatment,
then the oncologist must work to gain the acceptance of the client, and will
not make pronouncements. The careful design of the study permitted such nuanced
understandings of changes in doctor/patient medical encounters across time
within a context in medical conversation analysis (oncology) which has received
less attention than primary care.
There
are important policy implications for medical care which result from this
study. In the US physicians initially seek patients’ acceptance of treatment,
and therefore want the patient’s input. However, having obtained their signing
onto cancer treatments, physicians in the mid course context view patient agency
as having been somewhat transferred to them. Participants then have little
opportunity to consider alternative therapies, stop treatment or shift to
palliative or supportive care. The
paper makes important points in showing how this happens and, implicitly, in
providing for opportunities to medical staff to become aware of opportunities
to enhance the patient’s participation.
Marjorie Goodwin, Lorenza Mondada and Anssi Peräkylä
No comments:
Post a Comment